← Back to all signals
RESEARCH PAPER ANALYSIS

Hospitalization in the Intensive Care Unit of Children with Acute Lymphoblastic Leukemia: A Retrospective Cohort Study.

AI interpretation is pending for this paper.

Open original publication →
PMID42516634
JournalMedical journal of the Islamic Republic of Iran
Publication Date2026-01-12
Ingested2026-08-02 12:06 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: To examine how sociodemographic factors like age, gender, ethnicity, and socioeconomic status relate to early precursors of ALL (acute lymphoblastic leukemia), evaluate their distribution among Acute Lymphoblastic Leukemia (ALL) variants, FAB (French-American-British) classification, and comorbidities, and explore associated clinical profiles. Then, assess their significance on therapy outcomes in ICU (intensive care unit) settings. METHODS: A retrospective cohort study investigated the association between early detection of critical condition precursors and outcomes in pediatric ALL patients. Data from 188 ICU-admitted children were analyzed, exploring sociodemographic, clinical factors, and ICU outcomes, using SPSS for statistical analysis. Statistical methods included chi-square tests for categorical variables, independent sample t-tests for continuous variables, and multivariate logistic regression to identify prognostic factors influencing ICU outcomes. RESULTS: The study on ICU hospitalization of children with ALL revealed several important findings. Of 188 children admitted to the ICU, 98 (52.1%) were aged 8-18 years and 97 (51.6%) were male. Most participants had a weight ≤30 kg (56.9%) and reduced BMI (63.3%). The common ALL variant was most frequent (76, 40.4%). During ICU stay, 50 patients (26.6%) died and 138 (73.4%) were transferred to specialized oncology care. During the study period, 165 (87.8%) patients had a single ICU admission, while 23 (12.2%) experienced two or more ICU admissions. Male patients were more often transferred to oncology care (80/97, 82.5%; P=0.004). Mortality was significantly higher among those with reduced BMI (26/69, 37.7%; P=0.009) and concomitant diseases (15/33, 45.5%; P=0.007). Logistic regression identified male gender (Exp(B)=3.031, P=0.003) and concomitant diseases (Exp(B)=2.538, P=0.033) as significant predictors of adverse outcomes. Re-hospitalization frequency was associated with higher weight (mean 48.9 ± 23.3 kg vs. 27.7 ± 16.2 kg, P<0.001). CONCLUSION: This study identified key prognostic factors in pediatric ALL patients in the ICU, including gender, concomitant diseases, BMI, relapse, and risk group. These factors significantly influenced mortality and re-hospitalization rates, underscoring the importance of tailored management strategies for improved outcomes.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Nontuberculous mycobacterial infections in patients with hematologic diseases]. [Rinsho ketsueki] The Japanese journal of clinical hematology 64.4 2 [Fundamentals of genetic counseling in hematology: pedigree construction and management of secondary findings in HemeSight®]. [Rinsho ketsueki] The Japanese journal of clinical hematology 49.9 3 Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways. Cancer cell international 51.9 4 Knowledge and awareness of oral cancer and precancerous lesions among patients attending Dhaka Dental College Hospital: a cross-sectional study. BMC oral health 66.4 5 Changes in Body Weight Percentile During Primary Anticancer Treatment in Children: A Retrospective Single-Center Study. Cureus 64.74 6 Erratum: Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis. JCO global oncology 50.74 7 Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib. American journal of clinical pathology 62.42 8 Trachea, bronchus, and lung cancer in women of reproductive age: global burden trends from 1990 to 2021 and forecasts to 2035. Frontiers in global women's health 38.5 9 From missed diagnosis to lifelong survivorship: a precision oncology roadmap for equity in pediatric and AYA cancer care. Frontiers in oncology 61.8 10 Genomic rearrangements define a distinct biological state in neuroblastoma. Cancer genetics 57.2 11 Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases. World journal of pediatric surgery 71.44 12 A rare cause of dysphagia: A case report on gastroesophageal adenocarcinoma in childhood. JPGN reports 51.9 13 Patterns of high-risk histopathology features of retinoblastoma in enucleated and exenterated eyes at Tikur Anbessa Specialized Hospital: a retrospective study. Cancer treatment and research communications 67.9 14 Pediatric cancer and ethical decision-making: Who speaks for the child? Journal of pediatric nursing 65.3 15 Diagnostic evaluation of long-read nanopore sequencing for pediatric CNS tumors. Acta neuropathologica communications 57.5 16 Preventive Immunomodulatory Effects of Doxycycline and Hyperbaric Oxygen Therapy on Serum Tumor Necrosis Factor-α and Interleukin-6 Levels in a Rat Model of Malaria. Journal of parasitology research 58.44 17 Persistent Pediatric Cervical Lymphadenopathy: A Case Report of Kikuchi-Fujimoto Disease Mimicking Infection and Malignancy. Case reports in pediatrics 50.2 18 Cementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report. Case reports in dentistry 47.5 19 Global, Regional, and National Trends of Pediatric Soft Tissue and Other Extraosseous Sarcomas, 1990 to 2021: A GBD Study. Journal of pediatric hematology/oncology 60.4 20 Breaking the Barrier: MBI-LCBI and Recent Beta-lactam Exposure as Predictors of Piperacillin-Tazobactam Resistance in Pediatric Hemato-oncology Patients. The Pediatric infectious disease journal 69.4 21 Exploiting iron metabolism in Ewing sarcoma. Communications medicine 64.2 22 Unusual [18F]FDOPA PET-CT maging of insulinomas in children. EJNMMI reports 53.0 23 Spontaneous inversion of the left atrial appendage: a first autopsy case report and updated literature review. Cardiology in the young 45.5 24 Prognostic significance of end-of-induction measurable residual disease below 0.01% in pediatric B-lineage acute lymphoblastic leukemia. Cytometry. Part B, Clinical cytometry 65.8 25 Multiple Exposures to Antibiotics Affect Tumor Development in a Mouse Model of Early-Onset Colorectal Cancer. Carcinogenesis 50.9 26 Population-Based Assessment of Cardiometabolic Late Effects in 5-Year Survivors of Pediatric Acute Lymphoblastic Leukemia. Pediatric blood & cancer 69.2 27 Circulating Biomarkers of Disease Burden in Patients With Relapsed or Refractory Neuroblastoma Treated With 131I-MIBG Therapy: A Report From the New Approaches to Neuroblastoma Therapy Consortium. Pediatric blood & cancer 85.43 28 Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy. Pediatric blood & cancer 82.0 29 Surgical Margin and Risk of Local Recurrence in Children and Young Adults With Nonrhabdomyosarcoma Soft Tissue Sarcoma: A Nonrandomized Clinical Trial. JAMA surgery 86.8 30 Enzyme-functionalized β-cyclodextrin silicasomes for sequential stroma remodeling and combination chemotherapy in neuroblastoma. Journal of materials chemistry. B 61.64 31 Undescended Testes in Medically Complex Children: Evaluating A Common Urologic Condition Through a Multi-Disciplinary Lens. The Journal of urology 59.5 32 Brain-sensing synNotch-CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical models. Science translational medicine 66.0
PATIENT-FRIENDLY SUMMARY

Hospitalization in the Intensive Care Unit of Children with Acute Lymphoblastic Leukemia: A Retrospective Cohort Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic